24/7 Assess and support the treatment of patients at distancing using live video conferencing. Make patient follow-up visits simpler through live support of clinical staff and expands access to niche medical experts – in spite of their location
Labeling Types | Number of Labeling as of March 17, 2021 |
---|---|
Human OTC Drugs* | 88,579 |
Human Prescription Drugs and Biological Products** | 48,950 |
Animal Prescription and Animal OTC Products | 3,202 |
Human prescription drug and biological product labeling including prescribing information, patient labeling, and carton and container labeling:
Other biological products (e.g., blood products, allergenics, cellular therapy)
Human over-the-counter (OTC) labeling:
Approved drugs
Products marketed under the monograph system
Unapproved homeopathic prescription and homeopathic OTC products
Animal prescription and animal OTC product labeling
Other types of labeling:
Prescribing information for approved human prescription drug and biological products contains a summary of the essential scientific information needed for the safe and effective use of the product. It includes indications, dosage and administration, contraindications, warnings and precautions, adverse reactions, drug interactions, information about use in specific populations, and other important information for healthcare providers9. Associated patient labeling (e.g., Patient Information, Medication Guide, Instructions for Use)are directed to the patient, family, or caregiver. Associated container and carton labeling communicate information that is critical to the safe use of a medication from the initial prescription, to procurement, to preparation and dispensing of the product, to the time it is given to the patient.
Labeling for approved OTC drugs and OTC drugs under the monograph system is called Drug Facts. Drug Facts includes information about the purpose and use of the drug, warnings, directions for use, and other information.
Homeopathic prescription and homeopathic OTC drugs are not approved by the FDA but are allowed to be marketed. There are minimal labeling requirements for these unapproved products.
Labeling Types | Query Description | Query* | Result** |
---|---|---|---|
Labeling Full Text Search [Simple Search] | “Acute liver failure” | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |
Labeling Full Text Search [Simple Search] | “Respiratory depression” | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |
Labeling Full Text Search [Simple Search] | Biomarker “BRCA or BRAF” | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |
Labeling Full Text Search [Simple Search] | “Diabetes” within INDICATIONS AND USAGE | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |
“Beta blocker” within DRUG INTERACTIONS | “Diabetes” within INDICATIONS AND USAGE | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |
“Pregnancy or fetus” within BOXED WARNING | “Diabetes” within INDICATIONS AND USAGE | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |
“Pregnancy or fetus” within BOXED WARNING | “Diabetes” within INDICATIONS AND USAGE | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |
Labeling Full Text Search [Simple Search] | “Diabetes” within INDICATIONS AND USAGE | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |
Labeling Full Text Search [Simple Search] | “Diabetes” within INDICATIONS AND USAGE | https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/106525 | https://nctr-crs.fda.gov/fdalabel/ui/search/spl-summaries/criteria/106525 |